Press Releases

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
April 17, 2017

CRI Appoints Dr. Aiman Shalabi as Chief Medical Officer to Accelerate Precision Immunotherapy Clinical Collaborations

Nonprofit Cancer Research Institute appoints pharmaceutical executive to lead its clinical research program

March 28, 2017

BMS, Parker Institute, and CRI Team Up to Advance Immunotherapy Trials

Innovative collaboration model designed to accelerate next-generation precision cancer immunotherapy through network of leading research centers and top scientists

Collaboration will leverage efficiencies in cancer research to rapidly implement novel Immuno-Oncology clinical studies

Bristol-Myers Squibb is the first industry partner to join a collaboration with the Parker Institute and the Cancer Research Institute

January 31, 2017

CRI Awards Grant to Develop Powerful Genomic Data Resource

CRI iAtlas to provide immune bioinformatics tool that aims to improve cancer immunotherapy research and drug effectiveness.

December 06, 2016

CRI Partners with FCF in Rare Liver Cancer Research

The two nonprofits partnered to support four scientists whose research is focused on developing immunotherapies for patients with  fibrolamellar hepatocellular carcinoma.

December 01, 2016

Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens

Researchers at 30 organizations to test algorithms that predict tumor markers from DNA in hunt for new personalized cancer treatments.